North American Pit Viper Venom Protein Toxins

This target group encompasses a diverse array of proteinaceous toxins found in the venom of North American pit vipers, specifically from the genera Crotalus and Agkistrodon. These toxins include major enzymatic families such as snake venom metalloproteinases (SVMPs), which cause hemorrhage and tissue degradation, and phospholipases A2 (PLA2s), which exhibit neurotoxic, myotoxic, and inflammatory activities [1, 2]. Additionally, the group includes non-enzymatic proteins like disintegrins and C-type lectin-like proteins that interfere with platelet aggregation and the coagulation cascade [3]. In the context of clinical medicine, these proteins are the primary targets for polyvalent antivenoms like CroFab and Anavip, which utilize purified antibodies to bind and neutralize the toxins [4]. Understanding the synergistic effects of these proteins is crucial for treating snakebite envenomation, which can lead to systemic coagulopathy, local necrosis, and respiratory failure [5]. The term "other protein toxins" specifically refers to the minor components of the venom, such as cysteine-rich secretory proteins (CRISPs) and L-amino acid oxidases, which contribute to the overall pathophysiology of the bite. These toxins are highly conserved across related pit viper species, allowing for therapeutic cross-reactivity with antivenoms. Research into small molecule inhibitors, such as varespladib for PLA2s, aims to complement traditional antibody-based therapies by providing rapid, field-deployable treatment options.

Other names

Crotalinae venom proteinsPit viper toxinsCrotalid venom componentsCrotalus and Agkistrodon venom proteinsNorth American pit viper venom

Antibody-mediated neutralization and enzyme inhibition